Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01203722
Title Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center
Indications

hematologic cancer

Therapies

Tacrolimus

Sirolimus

Cyclophosphamide + Fludarabine + Mycophenolate mofetil

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.